Login / Signup

Clinical Associations with the differences in rivaroxaban dosing in patients with atrial fibrillation stratified by three renal function formulae.

Juhaina Salim Al-MaqbaliAbdullah M Al AlawiMaria Al-AdawiZubaida Al-FalahiAsia Al-AziziKholoud Al BadiMohamed Al Rawahi
Published in: Pharmacy practice (2022)
This study has shown a relatively high consistency with the gold standard in dosing rivaroxaban in AF patients using CG formula. Treatment efficiency and safety were not affected by the proportion of dose inappropriateness found in this cohort.
Keyphrases
  • atrial fibrillation
  • venous thromboembolism
  • end stage renal disease
  • newly diagnosed
  • pulmonary embolism
  • ejection fraction
  • patient reported outcomes
  • prognostic factors
  • patient reported
  • preterm infants